Compared with the lean participants who received saline+vehicle (from protocol I), baseline (after vehicle) FPI and HOMA-IR were elevated, and peripheral insulin sensitivity (M) was reduced in individuals with obesity (Supplemental Figure 3). This evidence concerns the gene INS and obesity disorder.